Skip to main content
logo
Vera Therapeutics logo
Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
29.89
+0.16 (0.54%)
Oct 9, 2026, 10:57 AM EDT - Market open

Vera Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2,1543,5952,678683535569
Market Cap Growth
9.57%34.24%291.87%27.69%-5.87%-
Enterprise Value
1,7323,1752,380553433482
Last Close Price
29.7350.6442.2915.3819.3526.72

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
5.255.954.646.726.968.17
P/TBV Ratio
5.265.954.646.726.968.17

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.190.130.100.530.410.07
Net Debt / Equity Ratio
-1.04-1.05-1.02-1.05-1.08-1.07
Net Debt / EBITDA Ratio
1.022.023.511.050.922.18
Net Debt / FCF Ratio
1.252.644.321.161.233.15
Quick Ratio
10.4113.4325.417.234.4810.36
Current Ratio
10.9213.6425.677.714.9110.73
Return on Equity (ROE)
-91.75%-50.71%-44.83%-107.50%-121.58%-54.43%
Return on Assets (ROA)
-46.76%-28.36%-25.14%-41.54%-52.81%-31.09%
Return on Capital Employed (ROCE)
-85.80%-46.30%-26.50%-66.60%-85.90%-45.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-18.76%-8.33%-5.68%-14.05%-16.64%-5.74%
FCF Yield
-15.82%-6.73%-5.07%-13.50%-12.64%-4.17%
Buyback Yield / Dilution
-12.23%-16.10%-29.55%-60.73%-97.76%-4099.14%
SEC Filings: 10-K · 10-Q